Bacterial, viral and other infectious agents

AB1_BACT_BIR_OTHER_INF_AGENTS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — B9[5-7] Hospital discharge: ICD-9 — 07[9-9]\|034[0-0] Hospital discharge: ICD-8 — 034[0-0]\|074\|078 Cause of death: ICD-10 — B9[5-7] Cause of death: ICD-9 — 07[9-9]\|034[0-0] Cause of death: ICD-8 — 034[0-0]\|074\|078 2 out of 7 registries used, show all original rules.	3643
4. Check minimum number of events None	3643
5. Include endpoints AB1_STREPTSTAPHYCOCC_INOTHER AB1_OTHER_BACT_INOTHER AB1_VIRAL_INOTHER	3643
6. Filter based on genotype QC (FinnGen only)	3643

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	AB1_BACT_BIR_OTHER_INF_AGENTS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	AB1_STREPTSTAPHYCOCC_INOTHER\|AB1_OTHER_BACT_INOTHER\|AB1_VIRAL_INOTHER
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B9[5-7]
HD_ICD_9	07[9-9]\|034[0-0]
HD_ICD_8	034[0-0]\|074\|078
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	B9[5-7]
COD_ICD_9	07[9-9]\|034[0-0]
COD_ICD_8	034[0-0]\|074\|078
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Bacterial, viral and other infectious agents based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	36180	13424	22611
Only index persons	31070	11109	19961
Unadjusted period prevalence (%)
Whole population	0.54	0.38	0.63
Only index persons	0.64	0.41	0.76
Median age at first event (years)
Whole population	20.92	22.23	19.95
Only index persons	20.34	21.08	19.93

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3643	1588	2055
Unadjusted period prevalence (%)	0.75	0.54	0.91
Median age at first event (years)	22.31	24.62	20.52

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3299: Matched controls
32987

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

0799X

ICD-9 Finland

Viral and chlamydial infection in conditions classified elsewhere and of unspecified site, Unspecified viral and chlamydial infections

+∞

323.0

374

0340A

ICD-9 Finland

Streptococcal sore throat and scarlatina, Streptococcal sore throat[TONSILLITIS STREPTOCOCCICA,STREPTOC BETAHAEMOLYT-A]

+∞

323.0

593

B97.7

ICD-10 Finland

Papillomavirus as the cause of diseases classified to other chapters

874.5

323.0

454

03400

ICD-8 Finland

Streptococcal sore throat and scarlet fever, Streptococcal sore throat

+∞

323.0

878

B96.2

ICD-10 Finland

Escherichia coli [E. coli] as the cause of diseases classified to other chapters

+∞

130.1

124

B97.4

ICD-10 Finland

Respiratory syncytial virus as the cause of diseases classified to other chapters

+∞

111.1

106

D14.1

ICD-10 Finland

Benign neoplasm: Larynx

34.1

95.3

125

D14.0

ICD-10 Finland

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

20.1

88.5

135

0340X

ICD-9 Finland

Streptococcal sore throat and scarlatina, Streptococcal sore throat[TONSILLITIS STREPTOCOCCICA,MUU STREPTOC BETAHAEMOL]

+∞

76.3

B96.5

ICD-10 Finland

Pseudomonas (aeruginosa) as the cause of diseases classified to other chapters

+∞

75.3

B95.6

ICD-10 Finland

Staphylococcus aureus as the cause of diseases classified to other chapters

+∞

75.3

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

14.5

65.2

112

0798X

ICD-9 Finland

Viral and chlamydial infection in conditions classified elsewhere and of unspecified site, Other specified viral and chlamydial infections

+∞

61.6

0790A

ICD-9 Finland

Viral and chlamydial infection in conditions classified elsewhere and of unspecified site, Adenovirus

+∞

59.5

N72

ICD-10 Finland

Inflammatory disease of cervix uteri

18.3

58.2

B96.1

ICD-10 Finland

Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified to other chapters

+∞

42.8

ULA02

NOMESCO Finland

Kolposcopy

2.6

40.7

318

1291

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.4

37.6

357

1609

ZXC10

NOMESCO Finland

Use of laser

4.9

37.3

125

261

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

2.5

35.7

300

1267

B977, D141

ICD-10 Finland

+∞

33.4

N771, B977

ICD-10 Finland

+∞

31.3

R50.9

ICD-10 Finland

Fever, unspecified

2.0

30.2

454

2487

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

29.3

795

5271

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

27.9

285

1321

B95.0

ICD-10 Finland

Streptococcus, group A, as the cause of diseases classified to other chapters

146.2

27.7

A41.9

ICD-10 Finland

Sepsis, unspecified

3.7

27.4

125

351

DQA10

NOMESCO Finland

Biopsy of larynx

12.5

26.3

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.9

25.6

107

279

ZXA00

NOMESCO Finland

Right side

1.6

24.9

688

4556

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

2.5

24.7

199

820

B97.8

ICD-10 Finland

Other viral agents as the cause of diseases classified to other chapters

+∞

24.0

B97.2

ICD-10 Finland

Coronavirus as the cause of diseases classified to other chapters

125.9

23.6

QA1S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in head

12.5

23.5

C03CA01

ATC

furosemide; systemic

1.7

23.2

553

3506

B977, D140

ICD-10 Finland

+∞

22.9

H02AB06

ATC

prednisolone; systemic

1.5

22.8

1272

9885

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

22.6

573

3693

DHB10

NOMESCO Finland

Excision of lesion of internal nose

14.2

22.6

J01MA02

ATC

ciprofloxacin; systemic

1.5

22.4

1044

7807

J01DA01

ATC

[U] cefalexin; systemic

1.4

22.3

1849

15506

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

4.3

22.2

201

B96.88

ICD-10 Finland

Other specified bacterial agents as the cause of diseases classified to other chapters

221.4

21.6

D38.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Larynx

12.9

21.1

B95.4

ICD-10 Finland

Other streptococcus as the cause of diseases classified to other chapters

+∞

20.8

B95.7

ICD-10 Finland

Other staphylococcus as the cause of diseases classified to other chapters

+∞

20.8

DHA10

NOMESCO Finland

Biopsy of cavity of nose

6.3

20.8

LDC03

NOMESCO Finland

Conisation of cervix uteri using diathermy or laser

2.8

20.6

138

509

J01DB01

ATC

cefalexin; oral

1.5

20.6

2532

22746

N02AX02

ATC

tramadol; systemic, rectal

1.4

20.5

1156

8950

ZXA10

NOMESCO Finland

Bilateral

1.7

20.4

459

2852

LDA10

NOMESCO Finland

Curettage of cervix uteri

3.0

20.4

123

426

J38.1

ICD-10 Finland

Polyp of vocal cord and larynx

7.9

20.2

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

2.0

20.1

288

1541

R03AC02

ATC

salbutamol; inhalant

1.4

20.1

1501

12249

B97.0

ICD-10 Finland

Adenovirus as the cause of diseases classified to other chapters

+∞

19.8

J01FF01

ATC

clindamycin; systemic

1.5

19.8

786

5648

LDB20

NOMESCO Finland

Electrocoagulation or laser therapy of cervix uteri

7.3

19.7

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

19.6

1084

8337

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

19.4

470

2981

7803A

ICD-9 Finland

General symptoms, Convulsions

5.0

19.4

125

J01MA12

ATC

levofloxacin; systemic

1.7

19.3

482

3085

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.3

18.8

176

783

R4110

NOMESCO Finland

Physiotherapy

1.5

18.7

706

5007

127

Kela drug reimbursment

Transplant complication

3.9

18.5

202

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

18.5

689

4871

ZXA05

NOMESCO Finland

Left side

1.5

18.1

623

4319

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.0

17.7

219

1106

DMB30

NOMESCO Finland

Transmaxillary excision of lesion of maxillary antrum

+∞

17.7

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

17.6

491

3227

UDQ22

NOMESCO Finland

Microlaryngoscopy

8.7

17.4

DNB30

NOMESCO Finland

Excision of lesion of ethmoidal sinus

42.2

17.3

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.7

16.8

346

2086

B96.80

ICD-10 Finland

Campylo bacterial infection causing disease classified in other paragraph

63.6

16.7

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.0

16.1

208

1066

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.3

16.1

244

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

16.0

541

3723

4630A

ICD-9 Finland

Acute tonsillitis[TONSILLITIS ACUTA]

2.6

15.8

114

444

LFB20

NOMESCO Finland

Destruction of lesion of vulva or perineum

8.0

15.8

0340G

ICD-9 Finland

Streptococcal sore throat and scarlatina, Streptococcal sore throat[TONSILLITIS STREPTOCOCCICA,STREPTOC BETAHAEMOLYT-G]

+∞

15.6

B96.0

ICD-10 Finland

Mycoplasma pneumoniae [M. pneumoniae] as the cause of diseases classified to other chapters

+∞

15.6

B95.3

ICD-10 Finland

Streptococcus pneumoniae as the cause of diseases classified to other chapters

+∞

15.6

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

15.4

370

2332

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

15.4

1500

12585

WX002

NOMESCO Finland

Sedation and analgesia

1.6

15.4

467

3133

A41.8

ICD-10 Finland

Other specified sepsis

4.6

15.1

115

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

15.0

200

1043

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

2.7

14.9

104

395

A11CC03

ATC

alfacalcidol; systemic

3.2

14.8

238

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.8

14.8

165

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

14.7

299

1797

N02BE01

ATC

paracetamol; systemic, rectal

1.4

14.7

2494

22775

0340C

ICD-9 Finland

Streptococcal sore throat and scarlatina, Streptococcal sore throat[TONSILLITIS STREPTOCOCCICA,STREPTOC BETAHAEMOLYT-C]

+∞

14.6

DM1BD

NOMESCO Finland

Extensive CT of paranasal sinuses and face area

8.1

14.5

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

14.3

537

3776

7806A

ICD-9 Finland

General symptoms, Pyrexia of unknown origin

4.8

14.2

100

A46

ICD-10 Finland

Erysipelas

1.7

14.2

337

2118

P01AB01

ATC

metronidazole; oral, rectal

1.4

13.8

1029

8229

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.2

13.8

235

L04AA01

ATC

[U] ciclosporin; systemic

3.8

13.7

156

4740A

ICD-9 Finland

Chronic disease of tonsils and adenoids, Chronic tonsillitis

2.4

13.7

114

481

N87.0

ICD-10 Finland

Mild cervical dysplasia

2.9

13.6

291

J01GB01

ATC

tobramycin; inhalant, parenteral

75.4

13.6

N03AX16

ATC

pregabalin; oral

1.5

13.5

586

4244

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

13.5

241

1391

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

13.5

419

2818

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

13.5

635

4678

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

13.3

299

1850

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

13.3

402

2688

J01AA02

ATC

doxycycline; systemic

1.3

13.0

2229

20122

UJF32

NOMESCO Finland

Coloscopy

1.4

12.8

579

4231

H02AB04

ATC

methylprednisolone; systemic

1.6

12.7

362

2384

J01CA04

ATC

amoxicillin; systemic

1.3

12.7

2447

22441

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.3

12.5

113

499

4452

FHL

Tonsil surgery

2.2

12.3

129

608

WX402

NOMESCO Finland

General anaesthesia

1.5

12.3

444

3089

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

12.2

740

5693

L28

ICPC

Limited function/disability (L)

1.6

12.2

310

1982

ZX120

NOMESCO Finland

Intravenous

1.8

12.1

223

1300

H02AB07

ATC

prednisone; oral

1.6

11.8

336

2210

N02AA05

ATC

oxycodone; systemic

1.6

11.8

296

1885

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

11.8

1293

10897

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

11.7

474

3375

J46

ICD-10 Finland

Status asthmaticus

2.8

11.7

269

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

11.7

945

7616

N06AB04

ATC

citalopram; systemic

1.4

11.6

538

3938

J01MA14

ATC

moxifloxacin; systemic

1.7

11.6

221

1302

B95.5

ICD-10 Finland

Unspecified streptococcus as the cause of diseases classified to other chapters

+∞

11.5

0340B

ICD-9 Finland

Streptococcal sore throat and scarlatina, Streptococcal sore throat[TONSILLITIS STREPTOCOCCICA,STREPTOC BETAHAEMOLYT-B]

+∞

11.5

L04AD01

ATC

ciclosporin; systemic

2.8

11.5

253

2121A

ICD-9 Finland

Benign neoplasm of respiratory and intrathoracic organs, Larynx

120.4

11.4

GB3AV

NOMESCO Finland

35.1

11.3

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

11.1

726

5648

J01FA06

ATC

roxithromycin; oral

1.3

11.0

1054

8692

J01EA01

ATC

trimethoprim; systemic

1.4

11.0

516

3789

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

2.4

10.9

368

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.5

10.9

324

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

10.8

266

1686

R06.0

ICD-10 Finland

Dyspnoea

1.4

10.8

546

4062

A10AA02

ATC

2.2

10.7

108

501

DPA25

NOMESCO Finland

Trephine of frontal sinus through nose

4.7

10.7

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

10.6

153

821

N18.8

ICD-10 Finland

Other chronic renal failure

2.7

10.6

260

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

10.5

168

935

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.1

10.4

116

565

03409

ICD-8 Finland

+∞

10.4

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.6

10.4

272

4658X

ICD-9 Finland

Acute upper respiratory infections of multiple or unspecified sites, Other multiple sites

4.8

10.4

R03BB01

ATC

ipratropium bromide; inhalant

2.6

10.3

291

TK800

NOMESCO Finland

Hemodialysis

2.7

10.3

267

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

10.3

225

1383

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

10.3

119

589

H02AB09

ATC

hydrocortisone; systemic

2.6

10.2

269

Z94.0

ICD-10 Finland

Kidney transplant status

3.4

10.1

139

R03BB04

ATC

tiotropium bromide; inhalant

1.8

10.1

186

1086

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

10.0

337

2307

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

10.0

194

1148

78020

ICD-8 Finland

Certain symptoms referable to nervous system and special senses, Convulsions

3.2

10.0

162

DM1DG

NOMESCO Finland

Paranasal sinuses and face area very extensive MRI examination with high intensity magnet

14.6

10.0

B03XA02

ATC

darbepoetin alfa; parenteral

3.0

10.0

179

38100

ICD-8 Finland

Otitis media without mention of mastoiditis, Acute

2.3

9.9

412

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

9.9

315

2126

R03DC03

ATC

montelukast; oral

1.5

9.8

397

2826

J01MA01

ATC

ofloxacin; systemic

1.7

9.8

190

1129

XF404

NOMESCO Finland

Ambulatory ECG

1.7

9.7

208

1269

A02BC02

ATC

pantoprazole; systemic

1.3

9.6

1697

15060

WX892

NOMESCO Finland

Monitored bed care

1.8

9.6

178

1040

DHB20

NOMESCO Finland

Polypectomy of internal nose

3.0

9.6

173

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

9.5

371

2624

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

9.4

175

1025

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.0

9.4

115

584

B96.7

ICD-10 Finland

Clostridium perfringens [C. perfringens] as the cause of diseases classified to other chapters

+∞

9.4

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.1

9.3

155

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.0

9.2

107

534

B01AB05

ATC

enoxaparin; parenteral

1.3

9.1

661

5206

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

9.1

154

875

A10AA01

ATC

2.2

9.1

431

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

9.1

1298

11207

R03BA02

ATC

budesonide; inhalant

1.4

9.0

423

3097

Z49.2

ICD-10 Finland

Other dialysis

4.9

9.0

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

9.0

272

1820

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.1

8.9

102

503

1420

FHL

Laryngomicroscopy

5.7

8.9

L04AA06

ATC

mycophenolic acid; systemic

2.7

8.9

228

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

8.8

556

4284

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.3

8.8

128

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.0

8.8

156

4659X

ICD-9 Finland

Acute upper respiratory infections of multiple or unspecified sites, Unspecified site

1.8

8.8

149

849

J45.8

ICD-10 Finland

Mixed asthma

2.3

8.7

320

R03BA05

ATC

fluticasone; inhalant

1.4

8.7

444

3299

A07AA02

ATC

nystatin; oral

1.9

8.7

122

649

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.3

8.7

344

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.8

8.7

202

J01FA09

ATC

clarithromycin; systemic

1.3

8.6

835

6850

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.2

8.6

414

N06AX11

ATC

mirtazapine; oral

1.3

8.6

804

6566

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.2

8.5

362

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

2.2

8.5

384

J04AB02

ATC

rifampicin; systemic

3.4

8.5

116

J02AC01

ATC

fluconazole; systemic

1.3

8.5

932

7773

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.8

8.4

153

890

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.8

8.4

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.3

8.3

319

UDQ02

NOMESCO Finland

Direct laryngoscopy

4.1

8.3

B95.1

ICD-10 Finland

Streptococcus, group B, as the cause of diseases classified to other chapters

+∞

8.3

N17.8

ICD-10 Finland

Other acute renal failure

3.9

8.3

137

Kela drug reimbursment

Uraemia requiring dialysis

3.8

8.3

A02BC01

ATC

omeprazole; systemic

1.3

8.3

622

4917

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

8.3

2085

19120

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

8.2

153

901

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

8.1

1011

8549

J47

ICD-10 Finland

Bronchiectasis

3.1

8.1

142

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

4.3

8.1

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

8.1

217

1411

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.0

8.0

485

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

8.0

188

1178

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.0

8.0

104

540

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

8.0

499

3834

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

8.0

228

1503

L17

ICPC

Foot/toe symptom/complaint

1.3

8.0

535

4161

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.2

7.9

128

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

7.9

680

5481

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.2

7.9

362

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

7.9

645

5160

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

2.2

7.9

338

J37.0

ICD-10 Finland

Chronic laryngitis

2.2

7.8

331

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

7.8

765

6273

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

7.8

200

1285

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

7.7

509

3948

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.9

7.7

159

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

7.7

153

918

R01AD08

ATC

fluticasone; nasal

1.3

7.6

745

6105

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

4.9

7.6

WX734

NOMESCO Finland

JET-ventilation

11.9

7.6

AA1AD

NOMESCO Finland

CT of head and brain

1.3

7.6

495

3831

CKC12

NOMESCO Finland

Photocoagulation of retina

1.9

7.5

103

549

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

7.5

377

2794

V03AE01

ATC

polystyrene sulfonate; oral

3.4

7.5

101

SPAT1255

SPAT

Intravenous administration of medicine

1.7

7.5

148

888

C03DA01

ATC

spironolactone; oral

1.6

7.5

192

1237

A05AA02

ATC

ursodeoxycholic acid; oral

2.7

7.4

169

UKC02

NOMESCO Finland

Cystoscopy

1.4

7.4

305

2177

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

3.7

7.4

A02BC05

ATC

esomeprazole; systemic

1.3

7.4

991

8432

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

7.4

169

1054

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

6.5

7.4

DMA00

NOMESCO Finland

Biopsy of maxillary antrum

13.4

7.4

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.6

7.4

180

1144

D07AA02

ATC

hydrocortisone; topical

1.4

7.3

337

2459

G80.2

ICD-10 Finland

Spastic hemiplegic cerebral palsy

+∞

7.3

A12AA04

ATC

calcium carbonate; oral

2.8

7.3

160

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

7.2

197

1284

M46.4

ICD-10 Finland

Discitis, unspecified

6.2

7.2

E0000UV

ATC

1.2

7.2

988

8428

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

7.2

478

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.0

7.2

478

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.5

7.2

203

N05BA01

ATC

diazepam; systemic, rectal

1.4

7.2

304

2186

B03XA01

ATC

erythropoietin; parenteral

3.9

7.1

DMB35

NOMESCO Finland

Endoscopic excision of neoplasm or another lesion from maxillary sinus

20.1

7.1

J01MA06

ATC

norfloxacin; oral

1.5

7.1

277

1956

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

7.1

136

809

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.7

7.1

129

756

R53

ICD-10 Finland

Malaise and fatigue

1.3

7.1

451

3474

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

7.1

240

1650

A63.0

ICD-10 Finland

Anogenital (venereal) warts

1.8

7.1

114

641

602

Kela drug reimbursment

Children's severe malnutrition

6.0

7.1

B05DA

ATC

Isotonic solutions

4.0

7.1

WW200

NOMESCO Finland

Immunization

2.0

7.1

424

M05BA04

ATC

alendronic acid; oral

1.7

7.1

127

742

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

7.1

123

709

XFE00

NOMESCO Finland

Epicardial ultrasonography

2.4

7.1

235

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

7.0

192

1255

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

7.0

534

4223

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.4

7.0

335

2462

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

4.9

7.0

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

6.9

228

1553

Z50.1

ICD-10 Finland

Other physical therapy

1.8

6.9

120

690

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

6.9

109

613

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.1

6.8

328

J38.3

ICD-10 Finland

Other diseases of vocal cords

3.2

6.8

104

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

6.8

124

726

J01XB01

ATC

colistin; inhalant, parenteral

40.1

6.8

4509

FHL

Other measure in this category

40.1

6.8

C09AA02

ATC

enalapril; systemic

1.4

6.8

371

2790

S97

ICPC

Chronic ulcer skin

1.8

6.8

104

578

48609

ICD-8 Finland

Pneumonia, unspecified

2.3

6.7

257

NHQ40

NOMESCO Finland

Amputation of toe

3.0

6.7

122

R01AD09

ATC

mometasone; nasal

1.2

6.7

1220

10714

4451

FHL

Guitar cutting

1.8

6.7

105

588

A02BA02

ATC

ranitidine; systemic

1.3

6.7

408

3126

R87.5

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal microbiological findings

3.0

6.7

117

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.1

6.6

106

R03AC12

ATC

salmeterol; inhalant

1.9

6.6

484

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

2.8

6.6

146

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

5.9

6.6

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.9

6.6

517

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.2

6.6

813

6841

L04AX01

ATC

azathioprine; systemic

1.7

6.5

117

683

QBB99

NOMESCO Finland

Other procedure for wound of skin of trunk

8.7

6.5

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.9

6.5

505

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

6.5

160

1018

N03AX12

ATC

gabapentin; oral

1.4

6.5

353

2649

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.7

6.5

130

782

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

5.0

6.5

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

6.5

241

1687

R03DA04

ATC

theophylline; systemic, rectal

1.9

6.5

514

J33.0

ICD-10 Finland

Polyp of nasal cavity

2.0

6.5

363

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

6.5

259

1843

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.3

6.4

LEB30

NOMESCO Finland

Destruction of lesion of vaginal mucosa

5.7

6.4

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.7

6.4

121

718

A10AE04

ATC

insulin glargine; parenteral

1.5

6.4

216

1484

WW500

NOMESCO Finland

Blood transfusion

1.9

6.4

476

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

6.4

499

3962

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

4.1

6.4

N05BA04

ATC

oxazepam; oral

1.3

6.4

579

4689

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

1.9

6.4

478

N06AX16

ATC

venlafaxine; oral

1.4

6.4

364

2757

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.2

6.3

276

N06AA09

ATC

amitriptyline; systemic

1.5

6.3

196

1319

N06AX21

ATC

duloxetine; oral

1.4

6.3

251

1782

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

6.3

487

07810

ICD-8 Finland

Other viral diseases of the conjunctiva, Epidemic keratoconjunctivitis

+∞

6.2

B95.2

ICD-10 Finland

Streptococcus group D and enterococcus as the cause of diseases classified to other chapters

+∞

6.2

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

6.2

198

1340

G47.3

ICD-10 Finland

Sleep apnoea

1.3

6.2

567

4595

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

6.2

271

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.4

6.2

208

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.4

6.2

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

6.2

177

1171

J01FA10

ATC

azithromycin; systemic

1.2

6.2

1648

14982

SPAT1254

SPAT

Administration of medicine

1.4

6.2

289

2116

R03AC03

ATC

terbutaline; inhalant

1.4

6.2

326

2438

ZX108

NOMESCO Finland

Inhalation

3.8

6.2

J01FA15

ATC

telithromycin; oral

1.4

6.2

251

1792

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

6.2

595

4858

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.6

6.1

170

1116

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

4.5

6.1

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.5

6.1

179

1189

46309

ICD-8 Finland

Acute tonsillitis, Unspecified

1.8

6.1

499

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

6.1

475

3766

J01DA06

ATC

[U] cefuroxime; systemic

1.4

6.1

350

2652

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

7.7

6.1

J01CA08

ATC

pivmecillinam; oral

1.2

6.1

765

6443

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.1

6.1

303

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.4

6.1

186

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.7

6.0

119

714

SPAT1229

SPAT

Assessment of need for aid

1.6

6.0

134

832

Z22.3

ICD-10 Finland

Carrier of other specified bacterial diseases

6.7

6.0

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.9

6.0

451

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.0

6.0

354

4453

FHL

Other and tonsil surgery

2.5

6.0

180

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3023368) Bacteria identified in Blood by Culture

1056

6892

1.75

46.98

6.6

4.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

653

4006

1.77

34.65

2.5

1.8

—

(42870588) Differential panel, method unspecified - Blood

1290

9583

1.54

31.23

8.6

6.4

—

(3002582) Erythrocytes [#/volume] in Urine

1104

8015

1.54

29.26

4.3

3.2

e6/l

92.4

103.1

0.06

883

6134

(3022096) Basophils/100 leukocytes in Blood

1660

13174

1.48

28.34

9.0

6.5

0.7

0.12

1591

12425

(3007853) Bacteria identified in Skin by Aerobe culture

540

3311

1.74

28.23

2.2

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

470

2772

1.80

28.08

2.2

1.7

—

(3030467) Casts [#/volume] in Urine by Automated count

1016

7297

1.54

28.06

4.2

3.1

e6/l

0.4

0.10

799

5469

(3001604) Monocytes [#/volume] in Blood

1791

14461

1.47

27.80

8.4

6.3

e9/l

0.6

1.41

1606

12657

(3006315) Basophils [#/volume] in Blood

1792

14504

1.46

27.26

8.4

6.3

e9/l

0.0

0.12

1607

12695

(3006504) Eosinophils/100 leukocytes in Blood

1692

13572

1.46

26.81

9.0

6.4

2.8

2.9

1.15

1624

12777

(3019069) Monocytes/100 leukocytes in Blood

1700

13655

1.46

26.71

9.2

6.7

8.6

8.5

0.08

1634

12925

(3019198) Lymphocytes [#/volume] in Blood

1832

14936

1.46

26.55

8.5

6.3

e9/l

1.9

2.0

4.20

1668

13325

(3002030) Lymphocytes/100 leukocytes in Blood

1745

14122

1.45

26.14

8.9

6.4

28.0

28.8

2.49

1671

13324

(3018010) Neutrophils/100 leukocytes in Blood

1723

13938

1.45

25.71

8.6

6.2

57.4

56.6

2.31

1654

13188

(3026782) Osmolality of Urine

754

5148

1.59

25.70

3.6

2.7

mosm/kgh2o

550.5

559.0

0.46

654

4421

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

466

2815

1.75

25.52

2.3

1.7

—

(3013115) Eosinophils [#/volume] in Blood

1832

15003

1.44

25.52

8.9

6.6

e9/l

0.2

0.64

1661

13356

(36304419) Bacteria [Presence] in Urine

993

7252

1.51

24.80

4.1

3.0

—

(3018095) Leukocytes [#/volume] in Urine

1238

9461

1.47

24.62

4.9

3.6

e6/l

46.4

72.6

1.14

936

6618

(3000850) Epithelial cells [#/volume] in Urine

790

5499

1.56

24.62

3.6

2.6

e6/l

4.9

5.4

0.65

691

4855

(3042936) Bacteria identified in Isolate by Culture

602

3942

1.63

24.27

2.5

2.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

457

2802

1.72

23.64

5.2

4.6

u/l

237.3

242.6

0.36

440

2669

(3013650) Neutrophils [#/volume] in Blood by Automated count

1972

16528

1.42

23.25

12.2

9.4

e9/l

4.2

4.1

1.51

1752

14508

(3020779) Urea [Moles/volume] in Serum or Plasma

398

2394

1.74

21.98

12.8

9.1

mmol/l

9.2

8.8

0.72

380

2302

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

619

4176

1.58

21.84

3.4

2.9

e6/l

3.0

2.1

1.03

372

2206

(3024561) Albumin [Mass/volume] in Serum or Plasma

1410

11274

1.41

21.01

7.0

5.2

g/l

35.4

36.3

6.44

1317

10562

(3027945) Reticulocytes/100 erythrocytes in Blood

410

2571

1.67

19.33

3.9

2.9

1.9

1.8

1.10

367

2312

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1683

13995

1.38

19.28

8.1

6.2

umol/l

10.9

11.6

1.84

1601

13292

(40758558) Short blood count panel - Blood

944

7131

1.44

18.93

9.8

7.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

623

4337

1.53

18.86

5.8

4.0

mmol/l

0.8

2.74

590

4103

(3026008) Bacteria identified in Urine by Culture

884

6611

1.45

18.68

3.3

2.8

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

632

4425

1.52

18.60

3.2

2.7

e6/l

1.0

0.9

0.44

382

2443

(3032080) INR in Blood by Coagulation assay

1281

10262

1.38

18.13

11.0

8.1

inr

1.2

0.33

411

3081

(3005719) IgG [Mass/volume] in Serum or Plasma

374

2328

1.68

18.10

3.3

2.6

g/l

10.3

10.5

0.27

333

2143

(3018418) pH of Serum or Plasma

966

7378

1.42

18.08

6.2

4.2

7.4

0.23

220

1453

(3033658) Prothrombin time (PT) actual/Normal

950

7245

1.42

17.90

6.1

4.2

90.5

92.3

1.40

927

7068

(3021589) Normoblasts [#/volume] in Blood

1553

12849

1.36

17.90

12.7

9.2

e9/l

0.0

0.72

1297

10594

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

8.05

17.89

2.5

2.3

mg/l

0.8

1.8

0.63

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

515

3485

1.56

17.65

3.4

2.6

22.1

24.1

2.60

460

3011

(3004789) Transferrin [Mass/volume] in Serum or Plasma

546

3749

1.54

17.51

3.2

2.5

g/l

2.3

2.4

0.84

514

3495

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

308

1839

1.74

17.35

2.1

1.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1887

16146

1.35

17.22

6.6

5.0

mmol/l

6.7

0.32

1786

15030

(3003458) Phosphate [Moles/volume] in Serum or Plasma

515

3509

1.54

17.08

10.8

7.0

mmol/l

1.1

1.0

1.38

493

3295

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

244

1369

1.84

16.96

2.2

1.6

—

(40768804) Tissue Pathology biopsy report

1334

10849

1.36

16.86

2.3

2.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

199

1056

1.94

16.43

1.8

1.9

g/l

1.5

0.23

169

917

(3031040) Bacteria [#/volume] in Urine by Automated count

2019

17526

1.34

16.36

5.2

3.9

e6/l

1660.4

1467.6

0.04

226

(3000991) Gas panel - Venous blood

359

2271

1.64

16.27

12.4

10.0

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1515

12612

1.34

16.25

10.6

7.2

mmol/l

1.2

0.09

1293

10728

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1337

10955

1.35

15.82

2.7

2.3

nmol/l

73.7

74.2

0.29

1251

10096

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2388

21310

1.35

15.77

10.4

7.3

u/l

80.0

76.6

2.47

2272

20219

(3022948) Iron [Moles/volume] in Serum or Plasma

575

4075

1.49

15.74

3.3

2.5

umol/l

12.6

14.1

5.01

548

3795

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

139

660

2.15

15.57

10.1

6.7

iu/ml

530.5

682.8

0.20

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

114

501

2.32

15.41

5.5

3.7

u/ml

583.6

1611.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

170

3.33

15.30

31.7

27.7

ug/l

131.3

123.5

0.27

138

(3014576) Chloride [Moles/volume] in Serum or Plasma

478

3282

1.53

15.21

9.5

8.0

mmol/l

104.4

104.3

0.20

472

3215

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

141

684

2.10

14.96

1.5

1.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

572

4090

1.47

14.92

3.4

2.4

30.1

29.7

0.78

552

3971

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

276

2.75

14.70

2.4

1.8

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

361

2345

1.60

14.66

9.5

8.4

mmol/l

1.3

1.4

0.45

348

2247

(3002032) Base excess in Venous blood by calculation

370

2419

1.59

14.62

7.5

4.5

mmol/l

1.5

1.8

1.18

327

1948

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

300

2.67

14.58

1.9

1.8

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

106

463

2.33

14.55

2.5

1.8

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

473

3271

1.51

14.52

4.3

3.1

umol/l

6.6

7.7

1.00

407

2853

(3020630) Protein [Mass/volume] in Serum or Plasma

301

1878

1.66

14.37

3.0

2.6

g/l

66.1

67.1

1.34

279

1754

(3021447) Carbon dioxide [Partial pressure] in Venous blood

370

2431

1.58

14.30

7.5

4.5

kpa

5.8

5.9

0.47

362

2363

(3028026) IgM [Mass/volume] in Serum or Plasma

290

1795

1.67

14.28

2.1

1.8

g/l

1.2

1.3

0.38

261

1672

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

311

2.61

14.11

2.3

1.8

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1369

11404

1.32

13.97

9.6

6.6

mmol/l

1.2

0.52

1280

10454

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

133

648

2.09

13.97

2.3

1.7

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

371

2.43

13.58

8.1

7.0

mg/l

11.7

10.8

0.96

343

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

130

637

2.08

13.46

2.4

1.8

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2322

20858

1.31

13.32

4.8

3.8

mm/h

11.8

10.1

6.01

2209

19553

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1202

9883

1.32

13.29

2.0

1.9

pmol/l

95.1

96.1

0.33

687

5444

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

807

6259

1.37

13.14

3.5

3.0

ng/l

1302.4

1198.5

0.28

688

5194

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

836

6528

1.36

13.03

2.3

1.9

mg/l

1.1

1.0

0.19

636

4901

(3037522) Nuclear Ab [Titer] in Serum

559

4083

1.44

12.90

1.4

1.3

titre

421.3

497.4

0.56

111

776

(3023520) Reticulocytes [#/volume] in Blood

293

1870

1.62

12.77

3.8

2.8

e9/l

77.5

72.3

1.09

223

1386

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

116

557

2.12

12.69

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

116

557

2.12

12.69

1.5

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

395

2705

1.52

12.63

3.4

2.7

u/l

46.1

56.7

0.22

340

2367

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

109

514

2.16

12.49

1.7

1.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1186

9798

1.31

12.49

3.8

3.2

ng/l

45.0

42.8

0.07

761

6004

(3044640) Blood type and Crossmatch panel - Blood

1053

8559

1.32

12.45

3.3

2.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

149

789

1.93

12.43

3.6

4.0

u/ml

0.3

0.16

423

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

118

576

2.08

12.37

5.0

3.8

56.1

57.1

0.38

118

576

(3017181) Myelocytes/100 leukocytes in Blood

347

2330

1.54

12.15

5.2

4.4

0.8

0.9

0.13

641

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

368

2503

1.52

12.14

3.1

2.5

g/l

0.2

0.68

343

2351

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

382

2620

1.51

12.12

3.8

3.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

976

7876

1.33

12.07

2.5

2.2

u/l

182.5

257.7

2.19

939

7486

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1046

8527

1.32

12.03

3.4

2.7

u/l

56.0

57.7

0.59

979

7966

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1463

12500

1.28

11.73

3.5

2.8

ug/l

147.1

126.8

1.10

1386

11729

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1209

10085

1.30

11.66

4.0

3.4

u/l

34.4

34.5

0.01

1156

9603

(3021601) Nitrite [Presence] in Urine by Test strip

1591

13757

1.28

11.53

5.4

4.5

estimate

0.0

0.50

344

2659

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

260

1654

1.62

11.49

7.3

4.0

mmol/l

1.7

1.5

0.36

194

1218

(3009261) Glucose [Presence] in Urine by Test strip

1603

13890

1.28

11.36

4.0

3.3

estimate

0.0

1.96

328

2516

(3025130) Human papilloma virus identified in Specimen

352

2.33

11.33

1.8

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

268

1724

1.60

11.31

7.3

4.0

kpa

5.1

0.44

254

1616

(3015377) Calcium [Moles/volume] in Serum or Plasma

1028

8426

1.31

11.22

3.9

3.3

mmol/l

2.3

2.4

0.99

936

7530

(3015235) Bicarbonate [Moles/volume] in Capillary blood

124

641

1.97

11.14

3.9

3.6

mmol/l

24.6

24.5

0.08

112

564

(3024354) Oxygen [Partial pressure] in Venous blood

304

2021

1.55

11.13

6.8

3.8

kpa

4.9

4.8

0.74

294

1958

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

225

1394

1.65

11.05

9.0

5.1

mmol/l

23.9

24.1

0.61

213

1275

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

382

2.25

11.00

2.0

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

1585

13756

1.27

10.94

3.9

3.2

estimate

0.0

0.80

329

2561

(3022217) INR in Platelet poor plasma by Coagulation assay

409

2907

1.46

10.84

23.8

20.6

inr

1.4

1.2

1.01

426

(3037467) Urinalysis macro (dipstick) panel - Urine

2129

19155

1.27

10.80

5.0

3.9

—

(3021440) Promyelocytes/100 leukocytes in Blood

326

2217

1.52

10.75

5.2

4.5

0.2

0.1

0.38

592

(3025159) Blasts/100 leukocytes in Blood

311

2095

1.53

10.72

5.4

4.5

0.0

0.4

0.90

496

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

465

2.12

10.71

1.8

1.5

—

(3009343) pH of Capillary blood

263

1709

1.58

10.64

7.4

4.0

7.4

0.10

204

(3048929) Epstein Barr virus Ab [Presence] in Serum

194

1170

1.70

10.56

1.5

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

142

789

1.83

10.27

3.0

2.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

849

6853

1.31

10.21

5.3

4.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

155

886

1.78

10.21

2.2

1.7

—

(3002179) Metamyelocytes/100 leukocytes in Blood

313

2137

1.51

10.13

4.9

4.2

0.6

0.10

475

(3023419) Bacteria identified in Sputum by Culture

314

2.32

10.03

5.2

2.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

157

907

1.76

9.98

4.8

2.9

176.9

180.7

0.23

149

870

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

158

917

1.76

9.89

5.6

3.2

g/l

3.5

3.6

0.09

152

870

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

3.46

9.73

2.9

2.2

u/ml

623.3

34814.8

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

264

1754

1.54

9.70

6.7

4.5

ng/l

108.9

87.2

2.59

227

1576

(46235355) HIV 1 and 2 tests - Meaningful Use set

842

6840

1.30

9.58

2.1

1.9

—

(3021960) Folate [Moles/volume] in Serum or Plasma

682

5397

1.32

9.36

1.5

nmol/l

20.6

20.0

0.47

614

4726

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

363

2.17

9.33

1.8

1.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

114

610

1.90

9.31

3.6

3.5

ratio

1.3

2.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

5.95

9.12

1.0

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

116

631

1.87

9.01

3.6

3.5

mg/l

80.0

39.7

0.39

500

(3023183) Ammonium ion [Moles/volume] in Plasma

116

633

1.86

8.93

4.0

3.3

umol/l

37.7

36.2

0.22

100

561

(3007164) IgA [Mass/volume] in Serum or Plasma

740

5964

1.30

8.85

1.6

1.5

g/l

2.4

0.03

487

3846

(3034860) Kappa light chains.free [Mass/volume] in Serum

115

630

1.85

8.75

3.6

3.5

mg/l

55.3

60.6

0.13

498

(3000494) Fungus identified in Specimen by Culture

448

3358

1.38

8.75

1.9

1.5

—

(3015736) pH of Urine

1235

10608

1.25

8.74

3.6

3.0

—

5.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

156

936

1.70

8.71

1.2

1.1

—

(44790047)

328

2.19

8.68

2.0

1.7

—

(44806118)

328

2.19

8.68

2.0

1.7

—

(44790049)

328

2.19

8.68

2.0

1.7

—

(44790048)

328

2.19

8.68

2.0

1.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

518

1.94

8.67

1.7

1.6

—

(40768797) Stomach Pathology biopsy report

483

3673

1.36

8.61

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

151

904

1.70

8.51

1.7

1.6

g/l

1.1

1.2

1.03

145

854

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

146

867

1.71

8.47

1.7

1.6

g/l

0.2

0.84

140

820

(3011397) Hemoglobin [Presence] in Urine by Test strip

756

6148

1.29

8.40

3.5

3.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

121

683

1.80

8.37

2.0

1.6

u/ml

103.0

110.7

0.30

141

(3036489) Thrombin time

185

1174

1.61

8.31

3.8

2.5

22.5

21.3

0.68

165

1017

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1478

12996

1.23

8.31

4.8

4.0

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

196

2.52

8.30

2.1

1.9

—

(40761536) Microorganisms panel - Urine sediment

331

2380

1.43

8.22

4.9

3.6

—

(3016750) Collection duration of Urine

168

2.64

8.19

3.2

2.1

min

493.4

502.1

0.26

129

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

132

770

1.74

8.18

2.9

2.2

g/l

10.0

10.4

0.70

113

671

(3052851) Hemolysis interference index of Serum or Plasma

136

802

1.72

8.11

4.4

3.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.76

8.11

2.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

284

1993

1.46

8.03

1.5

1.3

u/ml

220.3

258.4

0.37

273

1852

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

125

722

1.76

8.02

2.1

1.6

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

776

6365

1.28

8.01

2.5

2.1

mg/l

2.9

2.8

0.49

686

5467

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

123

709

1.76

7.95

2.7

2.4

g/l

0.3

0.9

2.07

107

640

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

636

5097

1.30

7.85

4.2

3.5

ng/l

437.3

503.0

0.24

463

3649

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2390

22149

1.23

7.82

3.5

3.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

125

730

1.74

7.73

2.0

1.5

u/ml

16.4

17.6

—

(40767503) Oxygen content in Capillary blood by calculation

100

548

1.85

7.65

3.3

2.5

17.2

17.0

0.18

287

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

113

643

1.78

7.65

2.8

2.2

g/l

0.0

0.06

102

604

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

134

2.78

7.63

1.8

1.4

—

(3021901) Oxygen saturation in Capillary blood

456

1.93

7.62

3.6

3.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3115

29791

1.31

7.62

20.3

12.5

mg/l

24.3

22.7

1.86

2609

23344

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

107

600

1.81

7.60

2.8

2.3

g/l

0.0

0.00

561

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

134

802

1.70

7.59

2.2

1.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

521

1.87

7.57

1.9

1.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

282

1999

1.45

7.57

5.5

4.0

mmol/l

1.2

1.46

256

1755

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

166

1052

1.61

7.53

4.2

2.9

93.8

92.6

0.24

155

983

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

157

982

1.63

7.51

2.7

1.9

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

124

729

1.73

7.50

1.2

1.3

iu/ml

8.3

8.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

204

1358

1.53

7.47

11.4

11.6

mmol/l

23.8

24.4

1.79

191

1286

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

106

596

1.80

7.47

2.8

2.3

g/l

0.0

0.00

560

(3028626) Oxygen [Partial pressure] in Capillary blood

117

679

1.75

7.41

8.1

4.5

kpa

8.7

0.10

111

631

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

128

762

1.70

7.41

1.6

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

131

785

1.69

7.40

3.0

2.2

g/l

3.1

0.26

108

633

(3024928) Oxygen saturation in Venous blood

108

613

1.79

7.38

7.6

4.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

786

6515

1.26

7.38

3.0

2.3

—

(3048689) Calprotectin [Mass/mass] in Stool

492

3838

1.33

7.37

3.0

2.6

ug/g

121.9

131.3

0.35

410

3136

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

344

2.06

7.36

1.6

1.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

194

1284

1.54

7.30

3.3

2.8

e6/l

0.2

0.19

188

1244

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

132

2.74

7.27

1.9

1.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

4.15

7.27

2.1

2.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

123

729

1.71

7.24

1.6

1.3

u/ml

262.1

258.7

0.05

468

(40760888) Immunoglobulin light chains.free panel - Serum

481

1.87

7.13

3.2

3.5

—

(3025941) Bacteria identified in Stool by Culture

251

1761

1.46

7.12

1.3

1.2

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

7.71

7.12

6.1

4.8

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

7.71

7.12

6.1

4.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

150

941

1.62

7.11

2.4

2.1

ug/l

3.4

1.7

0.32

137

847

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

135

826

1.66

7.06

3.0

2.2

g/l

3.8

0.08

104

617

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

135

827

1.66

7.03

3.0

2.2

g/l

7.2

0.06

109

650

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

135

827

1.66

7.03

3.0

2.2

—

(1616796) Gas panel - Central venous blood

102

578

1.79

7.03

4.5

3.9

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

523

4143

1.31

7.00

1.9

1.7

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.50

6.98

3.6

2.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2918

27758

1.26

6.89

16.3

11.1

ml/min/173m2

86.9

87.7

1.04

2502

22984

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

537

4284

1.30

6.81

3.1

3.0

mmol/l

2.4

0.69

465

3761

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

109

2.86

6.78

1.9

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

109

2.86

6.78

1.9

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

111

654

1.72

6.70

2.8

2.2

g/l

37.2

38.1

0.71

100

585

(4035726)

298

2182

1.40

6.69

1.5

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

251

2.17

6.59

4.7

3.5

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

134

2.63

6.54

1.3

1.1

iu/ml

3.6

4.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

356

2694

1.36

6.53

1.6

1.5

—

(3000330) Specific gravity of Urine by Test strip

172

1138

1.54

6.52

3.8

3.0

—

(3042631) Mycobacterium sp identified in Specimen

299

2.06

6.50

5.0

2.6

—

(21494815) CD4 cells/100 lymphocytes in Specimen

294

2.06

6.41

2.6

2.7

34.8

41.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

382

2931

1.34

6.40

8.7

kpa

12.3

12.5

0.33

367

2808

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

382

2931

1.34

6.40

8.7

kpa

5.1

0.04

368

2807

(3002385) Erythrocyte distribution width [Ratio]

2695

25479

1.22

6.39

22.2

15.1

13.6

13.5

1.54

2660

24971

(3019309) Folate [Moles/volume] in Red Blood Cells

516

4131

1.29

6.35

1.9

1.7

nmol/l

1108.6

1170.9

0.90

407

3198

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2343

21862

1.20

6.35

3.7

3.1

u/l

51.7

48.0

0.97

2233

20829

(3022313) Gas panel - Capillary blood

187

1268

1.50

6.33

8.3

4.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

670

5544

1.26

6.29

1.9

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

401

1.89

6.26

1.7

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

217

1521

1.45

6.22

1.7

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.52

6.15

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

239

2.15

6.13

1.4

1.3

u/ml

1.3

0.7

0.26

(3036481) Cortisol [Moles/volume] in Serum or Plasma

356

2721

1.34

6.12

2.5

2.2

nmol/l

364.5

366.9

0.07

332

2522

(3004588) Protein electrophoresis panel - Serum or Plasma

212

1485

1.45

6.10

2.8

2.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

227

2.17

6.06

2.6

3.1

e6/l

534.9

564.8

0.16

200

(3003396) Base excess in Arterial blood by calculation

379

2928

1.33

6.06

8.8

8.7

mmol/l

0.5

1.0

1.67

300

2304

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

128

2.59

6.03

2.2

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

128

2.59

6.03

2.2

1.7

—

(3037756) Immunofixation for Serum or Plasma

435

1.83

6.03

1.8

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

756

6371

1.24

5.99

1.6

1.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

222

2.18

5.97

2.6

3.2

e9/l

0.2

0.25

199

(3002256) Pathology report gross observation

428

3376

1.30

5.89

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

844

7210

1.22

5.86

4.3

3.6

estimate

0.0

1.94

324

2550

(3011412) CD3 cells [#/volume] in Blood

298

2.00

5.84

2.5

2.9

e9/l

1.3

1.2

0.27

181

(3012501) Base excess in Blood by calculation

590

1.70

5.79

4.8

4.5

mmol/l

3.0

2.4

1.18

389

(3013005) Retinol [Moles/volume] in Serum or Plasma

138

2.48

5.69

1.9

umol/l

2.0

0.07

129

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

127

2.53

5.61

2.4

2.8

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

139

910

1.55

5.57

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

138

903

1.55

5.55

2.9

2.5

ug/l

396.4

453.2

0.10

130

855

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

277

2070

1.37

5.53

2.4

au/ml

26.4

21.2

0.28

138

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.81

5.49

1.7

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

570

1.68

5.44

1.2

1.1

—

(3004775) Volume in Urine collected for unspecified duration

218

2.12

5.41

3.3

2.2

677.4

662.6

0.09

153

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

314

1.93

5.39

1.8

1.6

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.03

5.37

8.3

7.0

—

(40768443) Skin Pathology biopsy report

160

1089

1.49

5.36

1.2

—

(3010421) pH of Blood

111

696

1.61

5.36

5.5

4.4

7.4

0.01

579

(3045414) Leukocytes [Presence] in Urine

168

1157

1.47

5.32

2.1

1.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

240

2.06

5.30

1.2

u/l

71.4

75.9

0.09

179

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

309

1.92

5.30

1.7

1.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

359

1.85

5.28

1.3

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

148

997

1.50

5.22

1.6

iu/ml

0.3

6.2

0.48

199

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

186

1319

1.43

5.06

2.0

2.1

u/l

41.9

39.3

0.98

165

1187

(3042111) Morphology [Interpretation] in Bone marrow Narrative

374

1.81

4.96

2.3

1.8

—

(3051651) Icteric interference index of Serum or Plasma

173

2.21

4.96

5.5

3.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

196

1410

1.41

4.94

10.9

12.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.74

4.93

1.0

1.3

96.1

87.3

0.45

(3002331) Protein [Mass/volume] in Peritoneal fluid

3.13

4.91

1.5

1.4

g/l

29.6

23.8

0.77

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.78

4.87

2.0

—

(3016502) Oxygen saturation in Arterial blood

335

2625

1.30

4.86

9.4

9.2

96.0

95.8

0.26

326

2540

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

125

830

1.52

4.75

2.0

2.2

mg/l

10.0

11.0

0.81

117

779

(3024522) Salmonella sp identified in Specimen by Organism specific culture

314

1.86

4.75

1.8

1.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

202

1472

1.39

4.74

1.4

iu/l

22.3

23.3

0.18

159

1237

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

161

1127

1.45

4.72

9.1

4.4

mmol/l

24.6

24.7

0.16

153

1067

(3026493) Urate [Moles/volume] in Serum or Plasma

867

7562

1.19

4.72

3.2

2.5

umol/l

4012.5

3658.8

0.08

779

6769

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.95

4.71

1.0

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

225

2.01

4.65

2.6

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

225

2.01

4.65

2.6

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

225

2.01

4.65

2.6

1.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

232

2.00

4.64

3.4

2.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

551

1.63

4.58

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

311

1.85

4.57

1.8

1.6

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.41

4.56

4.9

3.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

248

1.95

4.53

5.7

4.2

—

(3014051) Protein [Presence] in Urine by Test strip

546

1.63

4.49

2.4

1.9

—

(40768446) Kidney Pathology biopsy report

149

2.23

4.43

1.8

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

169

2.14

4.40

4.1

3.0

u/ml

850.4

916.0

0.11

169

(3044290) Cell count panel - Cerebral spinal fluid

103

670

1.55

4.33

1.2

1.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

436

1.69

4.33

2.5

2.4

—

(3045142) Bone marrow Pathology biopsy report

267

1.88

4.30

1.8

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

414

1.70

4.30

1.3

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.59

4.30

2.1

1.7

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

127

868

1.48

4.24

1.2

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

199

2.02

4.22

1.8

1.5

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

234

1.93

4.20

2.3

2.4

11.1

12.4

0.37

125

(3026389) Candida sp identified in Specimen by Organism specific culture

335

1.77

4.19

1.4

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

313

1.80

4.19

1.8

1.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

159

1139

1.41

4.15

1.2

u/ml

0.3

0.8

1.24

(3005988) Vibrio sp identified in Specimen by Organism specific culture

314

1.80

4.15

1.8

1.6

—

(42529406) Shigella sp [Presence] in Stool by Culture

127

876

1.47

4.07

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

570

1.58

4.03

1.7

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

570

1.58

4.03

2.7

2.2

g/l

130.4

133.7

0.47

422

(3002173) Hemoglobin [Mass/volume] in Arterial blood

307

2443

1.28

3.99

10.0

9.6

g/l

121.4

124.9

2.08

300

2363

(3022145) Colonoscopy Study observation

377

3076

1.25

3.97

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

106

2.37

3.90

3.6

2.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

106

2.37

3.90

3.6

2.3

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

100

2.41

3.88

1.8

2.5

umol/l

32.8

28.4

0.50

(3003327) Ova and parasites identified in Stool by Light microscopy

149

1072

1.41

3.82

1.5

1.7

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

107

2.35

3.82

1.3

1.1

u/l

129.3

82.2

1.04

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

107

2.35

3.82

3.6

2.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

271

1.82

3.82

2.8

2.9

e6/l

585.6

710.2

0.60

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

124

865

1.45

3.77

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

895

7960

1.16

3.75

3.8

2.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1192

10834

1.15

3.71

4.1

3.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

279

2215

1.28

3.71

3.9

4.3

ug/l

24.0

19.8

0.13

215

1777

(3044007) Cell count panel - Peritoneal fluid

2.51

3.71

2.6

1.9

—

(3013512) EKG study

796

7021

1.17

3.70

3.9

3.4

—

(4062490)

334

1.72

3.67

1.3

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.69

3.65

1.2

1.1

—

(3044889) 12 lead EKG panel

2101

19843

1.14

3.64

3.8

3.3

—

(3028433) Virus identified in Specimen by Culture

2.38

3.64

1.6

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.61

3.63

1.0

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

254

1.82

3.62

1.4

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

123

864

1.44

3.62

1.2

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

546

1.55

3.60

1.2

1.3

u/ml

2.7

4.4

1.63

246

(3019977) pH of Arterial blood

123

2.20

3.60

3.1

7.4

0.21

(3004809) Band form neutrophils/100 leukocytes in Blood

390

1.65

3.58

5.2

3.4

1.7

1.3

0.37

319

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

130

2.16

3.57

3.5

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

130

2.16

3.57

3.5

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

130

2.16

3.57

3.5

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

130

2.16

3.57

3.5

2.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.36

3.57

3.1

3.8

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.40

3.55

1.1

91.9

91.0

0.06

(3023103) Potassium [Moles/volume] in Serum or Plasma

3073

29845

1.19

3.54

21.2

13.9

mmol/l

4.0

1.10

3018

29074

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.45

3.54

1.0

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

220

1.87

3.54

2.6

3.7

mu/l

22.1

31.2

0.94

212

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

613

1.51

3.54

1.1

1.2

u/ml

28.2

43.7

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

262

2078

1.28

3.52

2.4

2.3

ug/l

9.4

8.5

0.21

230

1874

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.18

3.49

8.3

8.2

mmol/l

5.2

6.9

1.17

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

112

2.24

3.47

1.1

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

100

681

1.48

3.47

1.3

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

100

681

1.48

3.47

1.3

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

242

1904

1.29

3.47

1.3

au/ml

27.8

56.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

145

2.08

3.47

1.2

1.9

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

434

1.60

3.42

2.9

2.3

umol/l

8.5

6.7

0.44

316

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

223

1.85

3.40

2.0

2.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

113

792

1.44

3.39

1.2

u/ml

21.5

41.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

274

2198

1.27

3.37

2.8

2.5

ml/min/173m2

62.5

72.2

2.83

116

791

(3049717) Cytology report of Urine Cyto stain

119

845

1.42

3.33

2.6

2.5

—

(3017704) Immunofixation for Urine

134

2.10

3.33

1.5

1.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

106

737

1.45

3.32

1.2

u/ml

3.8

7.8

—

105

(3033799) Differential panel - Peritoneal fluid

2.37

3.31

1.9

2.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3057

29713

1.18

3.31

20.9

13.8

mmol/l

139.5

139.6

3.98

3006

28998

(3024980) IgG subclass 4 [Mass/volume] in Serum

542

1.52

3.29

1.4

1.6

g/l

0.7

0.8

0.92

415

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

237

1873

1.28

3.29

3.6

3.0

ng/l

243.4

159.8

1.59

207

1670

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

640

1.48

3.28

1.3

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

226

1.82

3.28

1.7

1.5

—

(21494434) Karyotype in Bone marrow

212

1.85

3.26

1.4

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

331

1.67

3.26

1.3

g/l

0.4

0.16

226

(3027135) IgG subclass 1 [Mass/volume] in Serum

331

1.67

3.26

1.3

g/l

6.7

0.01

227

(3028192) IgG subclass 2 [Mass/volume] in Serum

332

1.67

3.22

1.3

g/l

2.9

3.0

0.20

229

(3014148) Varicella zoster virus Ab [Titer] in Serum

489

1.54

3.21

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

556

1.50

3.15

1.2

1.3

u/ml

2.7

4.2

0.61

188

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.36

3.15

1.0

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

119

856

1.40

3.12

3.3

3.8

u/ml

568.3

1782.3

0.49

106

737

(3024471) HLA-A [Type]

138

2.04

3.10

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

167

1.92

3.04

1.0

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

2.27

3.03

2.5

2.1

e6/l

53648.0

21416.8

0.35

(3000060) B lymphocytes [#/volume] in Blood

106

2.18

3.02

2.1

2.6

e6/l

281.9

276.5

0.02

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.90

3.02

1.0

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.90

3.02

1.0

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.41

2.96

1.4

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

111

797

1.41

2.96

1.4

ug/g

295.2

281.8

0.27

453

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2285

21836

1.12

2.94

3.9

3.7

pmol/l

14.5

14.6

0.65

2135

20241

(1761482) Bacteria [#/volume] in Urine by Culture

541

1.49

2.93

4.8

3.9

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

567

4957

1.17

2.93

1.9

1.5

1.4

0.43

501

4445

(3000093) Morphology [Interpretation] in Blood Narrative

235

1.75

2.92

1.1

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

177

1.87

2.90

1.0

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.10

2.88

1.3

1.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

111

803

1.39

2.85

1.3

1.5

mg/l

468.9

522.1

0.83

101

763

(3009542) Hematocrit [Volume Fraction] of Blood

2974

28924

1.15

2.83

19.5

13.2

40.7

41.0

1.47

2369

23002

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

745

6666

1.15

2.81

1.3

u/ml

1.5

1.8

0.30

202

1838

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

529

4616

1.17

2.80

1.3

u/ml

10.1

10.0

0.02

212

1920

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

506

1.49

2.79

1.2

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

498

1.50

2.79

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

397

3383

1.19

2.78

2.4

2.3

nmol/l

13.3

13.6

0.33

373

3079

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

647

1.43

2.77

3.6

2.4

ug/min

76.9

153.1

1.53

425

(3042733) HLA Ab [Presence] in Serum

152

1.92

2.74

6.1

4.9

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

152

1.92

2.74

1.6

1.5

u/l

13.6

6.6

0.61

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.20

2.73

9.7

4.0

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2723

26346

1.13

2.73

4.5

4.3

mu/l

1.8

2.1

2.26

2573

24603

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

5.01

2.72

2.3

1.4

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

6.01

2.70

3.2

1.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

502

1.48

2.69

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

105

2.10

2.68

2.4

2.3

e6/l

910.7

761.3

0.15

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

520

1.47

2.66

1.2

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

126

1.99

2.65

1.1

ng/l

4257.8

207.2

—

(4268621)

375

1.56

2.64

2.2

2.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

198

1.78

2.63

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

469

4074

1.17

2.63

1.7

1.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

266

1.66

2.62

1.7

1.4

g/l

30.7

33.3

0.78

236

(40757373) Influenza virus identified in Isolate

2.66

2.62

2.2

1.9

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

562

4954

1.16

2.61

1.3

iu/ml

31.1

28.7

0.18

193

1556

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

150

1156

1.31

2.59

1.6

1.4

—

(3030313) Adrenal Ab [Titer] in Serum

3.61

2.57

1.2

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

155

1202

1.30

2.56

2.5

2.3

—

(3036603) Volume of Urine

178

1.80

2.55

1.8

1.4

2200.2

2109.2

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

7.15

2.55

7.2

8.6

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

5.46

2.54

7.5

4.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

186

1.78

2.52

1.4

1.2

—

(4198724)

201

1.75

2.52

2.3

2.8

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3246

31841

1.18

2.48

20.3

13.9

umol/l

80.3

76.9

3.92

3246

31829

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.47

2.48

1.2

—

(3022621) pH of Urine by Test strip

206

1663

1.25

2.47

2.8

2.5

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.46

2.44

1.1

1.2

—

(3024932) HLA-DR beta [Type]

138

1.89

2.40

1.2

1.1

—

(40760410) HLA-B [Type] by High resolution

5.01

2.40

1.0

—

(40763590) HLA-DQ beta [Type]

5.01

2.40

1.0

—

(3013862) HLA-DP [Type]

5.01

2.40

1.0

—

(46236302) HLA-C [Type] by High resolution typing

5.01

2.40

1.0

—

(40760409) HLA-A [Type] by High resolution

5.01

2.40

1.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.35

2.38

1.0

1.2

97.5

80.3

—

(3017732) Neutrophils [#/volume] in Blood

243

2007

1.23

2.38

3.0

2.7

e9/l

4.4

4.1

0.74

195

1662

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

321

1.57

2.38

1.2

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2742

26613

1.12

2.37

5.5

5.0

mmol/mol

39.4

39.2

0.32

2593

25154

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

267

1.62

2.35

1.2

titre

307.1

206.8

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

154

1.82

2.33

2.1

3.0

umol/l

105.6

127.8

0.32

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

494

1.45

2.32

1.1

u/ml

1.5

2.7

1.98

256

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

162

1.80

2.30

2.0

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

470

4128

1.16

2.30

2.1

2.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

285

1.59

2.28

1.3

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

374

1.51

2.25

1.7

1.5

—

(40768795) Lymph node Pathology biopsy report

247

1.63

2.24

1.3

1.2

—

(3019060) Gas panel - Arterial blood

203

1657

1.24

2.24

4.8

5.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

263

1.60

2.23

2.7

2.4

—

(40761535) Cells panel - Urine sediment

241

2005

1.22

2.22

3.2

3.3

—

(3048879) Bone marrow aspiration report

2.34

2.21

2.6

2.8

—

(3006653) Thiamine [Moles/volume] in Blood

157

1.79

2.21

1.4

nmol/l

131.8

139.9

0.43

157

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

558

1.41

2.21

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

118

902

1.32

2.20

2.1

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

720

1.36

2.20

1.2

1.4

mmol/l

4.1

3.8

1.06

679

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

136

1.84

2.17

1.4

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.07

2.16

1.9

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

4.29

2.15

3.2

1.6

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

150

1190

1.27

2.13

1.1

—

21.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

236

1.62

2.10

1.7

1.4

e6/l

1524.2

2603.7

1.01

168

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.01

2.10

1.0

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

145

1.80

2.10

1.2

u/l

84.4

89.3

0.12

127

(40761511) CBC panel - Blood by Automated count

3202

31442

1.15

2.08

16.5

11.3

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

153

1.77

2.07

3.1

3.8

mg/l

7.9

8.1

0.07

131

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

165

1329

1.25

2.07

2.6

2.4

u/l

4944.5

6272.1

0.30

530

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

209

1729

1.22

2.05

3.0

3.4

pmol/l

4.5

4.6

1.06

192

1551

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.50

2.05

1.3

—

(3025315) Body weight

3.50

2.05

3.0

3.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

318

1.52

2.03

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

215

1.63

2.03

1.2

1.1

—

(3012516) Albumin [Mass/volume] in Urine

808

7414

1.12

2.01

3.6

3.4

mg/l

528.1

368.8

0.38

557

4893

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

3.08

2.01

1.5

1.7

mg/l

0.3

2.6

—

(3037121) Protein [Mass/volume] in Urine

122

953

1.29

1.98

3.7

3.6

g/l

0.4

0.14

466

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

446

3950

1.15

1.97

1.5

1.4

—

(4306422)

554

1.38

1.96

1.1

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.34

1.96

3.9

5.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

513

4589

1.14

1.95

2.2

2.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

134

1.80

1.95

2.5

2.0

mg/l

9.0

8.9

0.01

110

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.98

1.95

1.0

1.1

—

(3034426) Prothrombin time (PT)

127

1.82

1.93

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

142

1.77

1.92

1.2

1.1

u/l

25.1

17.4

0.53

123

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

142

1.77

1.92

2.1

1.5

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.16

1.88

1.0

1.2

78.0

72.8

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

300

1.51

1.87

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

433

1.42

1.85

1.3

1.4

u/l

26.2

21.5

0.48

356

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

485

1.39

1.82

5.3

3.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

206

1.61

1.82

1.6

1.4

e6/l

20644.9

83587.8

1.12

125

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.92

1.80

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.76

1.79

3.9

2.6

u/field

0.3

0.7

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.76

1.79

6.1

3.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

840

7770

1.11

1.79

4.5

4.1

mg/mmol

12.3

9.0

1.04

566

5156

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

159

1301

1.23

1.77

1.9

1.8

mg/l

3.6

4.0

0.28

116

910

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

102

1.87

1.76

2.1

1.7

au/ml

110.7

141.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.44

1.75

1.0

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.44

1.75

2.4

1.8

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.03

1.74

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.34

1.74

4.0

2.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

524

1.36

1.74

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

132

1.75

1.73

1.6

1.7

—

(3007566) Smooth muscle Ab [Titer] in Serum

110

866

1.28

1.72

1.5

1.3

titre

75.0

84.2

0.19

(3022493) Free Hemoglobin [Mass/volume] in Plasma

140

1.72

1.71

7.2

6.3

mg/l

59.1

69.3

0.42

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

140

1.72

1.71

2.1

1.5

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.85

1.71

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

291

1.48

1.69

1.1

mg/l

255.3

274.6

0.33

252

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

136

1101

1.24

1.69

1.8

3.0

u/ml

33.8

47.3

0.79

128

1065

(3009214) Lutropin [Units/volume] in Serum or Plasma

149

1219

1.23

1.68

1.5

1.4

u/l

8.1

7.7

0.15

113

992

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

136

1102

1.24

1.67

1.8

1.7

—

(4212803)

3.16

1.66

1.0

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

193

1623

1.20

1.66

1.3

1.4

—

(3003694) ABO and Rh group [Type] in Blood

935

8727

1.10

1.65

1.6

1.5

—

(3000492) Spirometry study

370

3282

1.14

1.63

1.6

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

112

891

1.27

1.62

2.1

1.9

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.57

1.61

13.8

6.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

110

874

1.27

1.61

1.1

u/ml

1.5

6.0

1.88

130

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

143

1.68

1.60

2.7

3.1

au/ml

47.7

105.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

574

5235

1.11

1.60

1.7

1.6

pmol/l

28657763.5

31553605.6

0.05

499

4494

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

215

1.54

1.56

2.2

3.0

51.6

42.6

—

(4015189)

2.11

1.55

10.5

2.6

—

(3035880) pH of Pleural fluid

107

1.78

1.54

1.5

1.3

—

(4010399)

222

1905

1.18

1.53

1.5

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

467

1.36

1.53

1.2

1.1

g/l

1.4

1.5

0.18

428

(3026480) Teichoate Ab [Titer] in Serum

2.86

1.50

1.3

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

108

1.76

1.50

1.9

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

899

8410

1.09

1.50

3.7

3.4

mmol/l

8.1

8.3

0.62

774

7281

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.95

1.48

4.4

2.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.95

1.48

4.4

2.7

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.00

1.48

1.5

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

453

1.35

1.48

1.3

1.4

pmol/l

61.6

143.9

0.67

143

(21494814) CD8 cells/100 lymphocytes in Specimen

109

1.75

1.46

2.7

2.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

211

1.52

1.45

1.9

1.7

—

(3045788) Cell count panel - Pleural fluid

187

1.56

1.45

1.7

1.5

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

237

1.48

1.41

2.2

2.5

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

149

1.61

1.40

1.0

ng/l

753.3

788.2

0.16

100

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

722

1.27

1.39

1.3

1.6

e6/l

6.2

28.2

1.61

550

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

722

1.27

1.39

1.4

1.7

e6/l

217.0

1293.4

1.57

580

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

306

1.41

1.36

1.1

1.2

mg/l

46.4

41.7

0.21

247

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

151

1.59

1.34

1.0

ng/l

282.0

262.8

0.12

104

(3009466) Valproate [Moles/volume] in Serum or Plasma

522

1.31

1.34

7.0

5.7

umol/l

382.8

367.6

0.43

458

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

866

0.77

1.34

1.4

1.5

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

375

1.37

1.34

1.6

1.3

nmol/l

0.5

0.6

2.37

362

(44816559) Phosphatidylethanol [Mass/volume] in Blood

735

1.26

1.34

1.5

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

2.15

1.33

2.4

1.7

—

(36660697) Celiac disease serology panel - Serum

273

2411

1.14

1.32

1.1

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

152

1.58

1.31

1.0

ng/l

40.9

38.0

0.15

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

139

1165

1.20

1.30

2.0

pmol/l

210.8

207.9

0.13

133

1115

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.36

1.29

1.8

4.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.78

1.28

1.0

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

336

1.37

1.27

1.6

1.3

nmol/l

—

(3014271) Vancomycin [Susceptibility]

1.72

1.27

3.6

2.6

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.29

1.26

2.6

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

185

1594

1.17

1.26

7.4

7.8

mmol/l

24.6

24.5

0.24

174

1495

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2909

28590

1.09

1.25

3.8

3.7

mmol/l

1.4

2.76

2747

26899

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.74

1.25

1.1

1.3

nmol/l

137.3

135.2

0.02

(3034891) Synovial lining cells/100 cells in Synovial fluid

123

1.63

1.24

1.5

1.6

7.8

3.8

0.66

(3017509) Phencyclidine [Presence] in Urine

2.00

1.23

4.1

1.5

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.91

1.22

2.4

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.91

1.22

2.4

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

347

1.36

1.22

1.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.63

1.21

1.0

1.3

u/l

4.2

12.7

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.16

1.21

1.0

1.2

—

(3021788) Differential panel - Synovial fluid

487

1.30

1.21

1.6

—

(40765096) Chromosome analysis panel by Banding

1.80

1.21

1.1

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

124

1.62

1.20

1.1

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

205

1.47

1.19

2.7

2.3

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

2.31

1.18

5.0

4.0

—

(40768806) Pleura Pathology biopsy report

214

1.45

1.18

1.6

1.5

—

(3003181) Sodium [Moles/volume] in Urine

402

1.32

1.17

1.4

mmol/l

59.8

66.8

0.56

326

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

198

1.47

1.16

1.1

—

(4027681)

240

1.42

1.15

1.2

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

240

1.42

1.15

5.2

3.4

62.1

55.9

0.87

165

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

2.50

1.15

1.0

1.4

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

232

1.43

1.15

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

283

1.38

1.14

6.5

3.9

—

(3020491) Glucose [Moles/volume] in Blood

224

1.43

1.14

1.8

1.6

mmol/l

7.1

6.6

0.34

152

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

142

1.55

1.14

2.4

1.9

umol/l

26.5

28.3

0.42

135

(3023511) Choriogonadotropin [Units/volume] in Urine

663

1.24

1.12

1.3

—

(4281824)

225

1.43

1.12

1.2

—

(4094501)

102

845

1.21

1.11

1.1

—

(3001556) Androgen free Index in Serum or Plasma

1.96

1.11

1.6

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

354

1.33

1.10

1.1

1.7

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

144

1.53

1.08

1.1

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

278

1.37

1.07

1.6

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

339

1.33

1.06

1.7

1.3

—

(40768441) Liver Pathology biopsy report

211

1.43

1.06

1.6

—

(3011985) Renin [Units/volume] in Plasma

366

1.32

1.05

1.8

1.5

mu/l

87.0

57.6

0.33

328

(3047181) Lactate [Moles/volume] in Blood

100

834

1.20

1.03

5.2

7.1

mmol/l

1.3

0.13

726

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.74

1.02

5.8

7.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

267

2402

1.12

1.02

2.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

213

1.41

1.01

1.1

1.0

—

(4024509)

188

1.44

1.01

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

147

1.50

1.00

1.1

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

214

1.41

0.99

1.1

1.0

—

(3012441) Differential panel - Pleural fluid

206

1.41

0.98

1.9

1.4

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

2.18

0.98

1.0

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3231

31971

1.09

0.97

12.9

9.5

u/l

28.8

29.2

0.66

3162

31090

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.4

—

2.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.95

0.97

1.1

1.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

328

1.31

0.95

3.7

2.9

nmol/l

0.8

0.9

0.53

250

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

149

1.48

0.95

1.1

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

461

1.26

0.95

1.4

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.77

0.94

1.2

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

403

3727

1.09

0.91

1.7

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.14

0.91

1.2

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.63

0.90

1.1

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.75

0.90

2.5

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

323

1.30

0.89

1.7

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

118

1015

1.17

0.89

4.6

6.1

1.9

1.7

0.97

111

950

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

457

1.25

0.88

1.7

1.5

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

152

0.59

0.88

2.4

2.1

nmol/l

155.1

159.7

—

132

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.65

0.88

1.0

2.4

umol/l

15.3

16.2

0.10

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

289

1.32

0.88

1.1

—

(40758292) HTLV I+II Ab panel - Serum

1.79

0.87

1.8

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

159

1401

1.14

0.87

1.5

1.6

mu/l

271.2

284.5

0.31

138

1284

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.61

0.87

1.4

1.5

ug/l

7.6

8.3

0.38

(21494755) Public health laboratory ask at order entry panel

418

4495

0.92

0.87

1.4

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.72

0.86

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.82

0.85

1.0

—

(1002224) Polysomnography panel

194

1735

1.12

0.85

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

204

1.38

0.85

1.1

iu/ml

12.6

8.8

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

179

1.40

0.84

1.1

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

205

1.37

0.83

1.6

2.8

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

111

0.54

0.83

1.0

1.1

—

(3011648) Oxygen content in Venous blood

257

1.33

0.83

3.2

4.1

12.0

11.3

0.61

257

(3017569) Oxygen content in Arterial blood

113

1.51

0.82

1.5

2.8

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.79

0.0

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.82

0.79

1.0

1.2

—

(3016031) Almond IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.1

—

2.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

103

888

1.16

0.78

1.6

1.8

—

(3004451) EKG impression Narrative

131

1.45

0.78

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

211

1909

1.11

0.78

2.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

126

0.55

0.77

1.9

1.6

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.77

0.76

1.0

1.2

umol/24h

1.5

2.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.77

0.76

3.2

3.6

—

(3002619) Bacteria identified in Specimen by Culture

1.70

0.75

1.1

1.2

—

(3045424) Erythrocytes [Presence] in Urine

468

1.22

0.74

1.6

1.5

—

(21491868) Cryoglobulin [Mass/volume] in Serum

116

1.47

0.74

1.2

1.1

g/l

—

0.1

—

(3047189) Immunofixation for 24 hour Urine

100

1.50

0.72

2.1

1.7

—

(3028707) Methadone [Presence] in Urine by Screen method

774

1.17

0.72

2.6

3.1

—

(3042517) Benzodiazepines panel - Urine

1.61

0.72

3.3

2.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

159

1.39

0.72

1.4

1.1

miu/ml

1420.7

1527.5

0.15

159

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

274

1.28

0.69

1.6

1.5

g/l

1.0

0.06

274

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

773

7400

1.06

0.69

1.6

1.7

mmol/l

1.5

1.02

670

6374

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

118

1.44

0.69

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.60

0.68

6.5

7.1

—

(3004616) Nuclear Ab [Presence] in Serum

311

1.26

0.67

1.6

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1036

0.87

0.67

1.7

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3002

29710

1.06

0.67

4.2

4.0

mmol/l

4.7

0.21

2847

28158

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.63

0.66

1.4

2.2

—

(3007461) Platelets [#/volume] in Blood

3406

33855

1.09

0.66

26.6

18.0

e9/l

252.8

252.0

0.29

3360

33146

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.79

0.66

1.4

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.79

0.66

1.0

1.1

—

(3014891) Appearance of Pleural fluid

1.79

0.66

2.6

1.7

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

670

1.17

0.65

4.0

2.5

nmol/l

1.0

0.8

0.82

571

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

745

1.16

0.65

1.3

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

313

1.25

0.65

1.6

1.7

61.8

59.1

0.17

209

(3019150) Specific gravity of Urine by Refractometry

619

5902

1.06

0.64

4.1

3.5

kg/l

1.0

1.92

837

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

120

1.42

0.64

2.0

1.2

—

(3011288) Drugs identified in Urine by Screen method

134

1198

1.12

0.64

2.3

3.3

—

(3026361) Erythrocytes [#/volume] in Blood

3409

33892

1.09

0.64

26.6

18.0

e12/l

4.6

6.72

3361

33103

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

198

1.32

0.64

1.0

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

113

1002

1.13

0.62

5.0

6.2

0.9

0.06

106

939

(3024731) MCV [Entitic volume]

3408

33886

1.09

0.62

26.5

18.0

90.6

90.4

2.28

3377

33523

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

406

1.21

0.62

1.3

—

(3044927) Protein electrophoresis panel - Urine

217

1.29

0.61

1.1

—

(3000012) Reticulocyte production index

113

1.42

0.61

1.3

1.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2985

29559

1.05

0.61

4.1

4.0

mmol/l

1.4

3.36

2833

27904

(3010813) Leukocytes [#/volume] in Blood

3409

33900

1.09

0.60

26.7

18.1

e9/l

6.9

6.7

4.03

3358

33111

(3020874) Milk IgE Ab [Units/volume] in Serum

227

1.28

0.59

1.2

1.1

u/ml

0.3

4.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

445

1.19

0.59

3.2

3.7

u/ml

142.3

747.8

0.56

415

(3035941) MCH [Entitic mass]

3407

33883

1.09

0.59

26.5

17.9

30.3

0.50

3379

33518

(3000285) Sodium [Moles/volume] in Blood

1.72

0.57

1.2

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

1.72

0.57

1.5

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

181

1974

0.91

0.57

1.7

1.6

—

(1761868) Lipid panel - Serum or Plasma

1281

12472

1.04

0.57

2.6

2.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

193

1.30

0.57

1.2

1.4

u/l

5.1

6.9

1.52

165

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.48

0.57

1.0

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

216

1995

1.09

0.57

1.2

iu/ml

147.1

158.5

0.15

744

(3035320) C reactive protein [Mass/volume] in Body fluid

202

1.29

0.57

3.4

2.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

449

1.18

0.55

1.4

1.2

u/l

59.0

42.0

0.28

386

(3027944) Amphetamines [Presence] in Urine

192

1769

1.09

0.54

2.0

2.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

786

1.14

0.54

4.9

4.3

mmol/l

4.0

3.9

1.17

740

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.58

0.54

1.8

1.9

ng/l

173.0

121.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.46

0.54

2.1

2.0

—

(3000963) Hemoglobin [Mass/volume] in Blood

3408

33905

1.08

0.54

26.8

18.1

g/l

137.5

139.1

8.06

3383

33536

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

204

1.28

0.54

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

276

1.23

0.54

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

169

1.30

0.53

1.7

1.5

umol/l

22.5

25.1

0.16

161

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.43

0.52

2.0

3.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3030

30048

1.05

0.52

4.5

4.4

mmol/l

2.9

0.13

2868

28306

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.50

0.51

1.2

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.50

0.51

1.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

630

1.15

0.51

1.7

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

287

1.22

0.51

1.4

1.3

nmol/l

1.5

1.4

0.04

262

(3016879) Cocaine [Presence] in Urine

183

1689

1.09

0.51

2.0

2.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

179

1651

1.09

0.51

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

194

1796

1.08

0.50

1.9

2.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

127

1.34

0.49

1.0

1.1

—

(3027008) Opiates [Presence] in Urine

195

1808

1.08

0.49

1.9

2.1

—

(4133840)

101

1.39

0.49

1.1

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

216

1.25

0.49

1.1

1.2

ratio

1.1

1.0

1.79

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

708

1.13

0.49

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.45

0.48

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

172

1.28

0.48

1.3

—

(3028300) Cannabinoids [Presence] in Urine

195

1811

1.08

0.48

2.0

2.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

128

1.33

0.47

1.0

—

(40768793) Breast Pathology biopsy report

466

1.16

0.47

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

272

1.22

0.47

1.2

1.1

—

(3020891) Body temperature

113

1027

1.10

0.45

5.3

4.9

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

192

1.25

0.44

1.4

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

1.40

0.44

1.0

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

247

1.22

0.44

1.8

1.6

29.6

30.5

0.06

156

(3024869) Neuronal Ab [Presence] in Serum

1.37

0.44

1.3

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

153

1414

1.09

0.43

1.9

2.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

377

1.17

0.43

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

104

1.35

0.43

1.8

2.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

194

1.24

0.42

1.0

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.52

0.41

1.0

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.1

—

0.7

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.47

0.40

1.0

1.1

—

(3019225) pH of Specimen

244

2305

1.06

0.40

7.0

4.2

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

812

0.90

0.39

1.7

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

233

1.20

0.38

1.7

1.6

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

1.36

0.38

1.4

1.3

40.0

33.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.34

0.38

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

252

1.19

0.37

3.5

3.2

mg/l

85.1

75.5

0.06

193

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

267

2535

1.06

0.37

1.5

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1061

10377

1.03

0.37

3.8

3.7

ug/l

2.8

2.0

0.79

973

9491

(3013139) Helicobacter pylori Ag [Presence] in Stool

192

1805

1.07

0.37

1.1

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.35

0.37

1.2

1.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

955

0.91

0.37

1.6

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

567

0.88

0.37

3.5

3.3

mg/l

25.0

26.1

0.10

368

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2825

28035

1.03

0.36

4.1

4.0

mmol/l

5.9

1.14

2655

26128

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

859

1.10

0.36

1.6

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

954

0.91

0.36

1.6

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

954

0.91

0.36

1.6

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

180

1.22

0.36

2.6

2.1

u/field

2.7

2.0

0.28

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.43

0.35

1.2

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.31

0.35

2.2

2.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

208

1.20

0.35

1.0

1.1

u/l

0.9

1.1

—

104

(3044941) Cell count panel - Synovial fluid

423

1.14

0.35

1.6

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

388

3730

1.05

0.34

1.8

1.7

—

(44806071)

1.36

0.34

1.2

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

1.36

0.34

2.2

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

528

1.12

0.34

1.4

1.5

nmol/l

0.8

0.4

0.65

420

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

950

0.91

0.34

1.6

1.4

—

(3045716) Anion gap in Serum or Plasma

127

1.26

0.33

3.3

2.4

mmol/l

7.7

9.6

0.87

(3015183) Erythrocyte sedimentation rate

210

0.81

0.33

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

663

1.10

0.33

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

292

3052

0.95

0.33

8.2

6.3

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.30

0.33

1.2

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

791

0.91

0.32

1.6

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

341

3549

0.96

0.32

1.7

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

238

1.18

0.32

1.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

788

0.91

0.30

1.6

1.4

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

131

0.76

0.30

8.4

5.8

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

131

0.76

0.30

4.2

2.9

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

808

8265

0.97

0.30

3.4

3.3

22.2

21.3

0.75

292

3106

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

277

1.16

0.30

2.4

mg/l

25.5

23.9

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

221

1.18

0.30

2.2

1.9

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.31

0.30

1.5

1.3

umol/l

17.7

17.0

0.14

(3051593) INR in Capillary blood by Coagulation assay

1.31

0.30

3.5

12.8

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

679

1.09

0.29

1.1

u/ml

1.1

2.4

1.68

169

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.29

0.28

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.25

0.27

1.0

1.6

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

578

1.09

0.25

1.1

iu/ml

47.6

942.5

0.54

148

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

704

1.08

0.25

1.6

2.0

iu/l

3.8

4.5

0.35

272

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.22

0.25

2.2

1.6

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

236

1.15

0.24

1.1

1.3

—

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

255

1.14

0.24

4.0

5.2

u/ml

21.8

80.2

1.23

(44813793)

201

0.85

0.23

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

1.25

0.22

1.1

1.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.25

0.22

11.2

10.9

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

709

1.07

0.22

1.0

1.1

u/ml

3.6

5.8

0.98

383

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

219

1.14

0.22

1.4

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.19

0.21

5.0

8.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.3

—

2.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.3

—

(3023410) Appearance of Cerebral spinal fluid

334

1.11

0.21

1.3

2.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

156

0.83

0.21

1.0

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

1.25

0.20

1.7

2.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

221

1.13

0.20

1.4

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.20

0.19

1.0

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

626

1.07

0.19

1.6

1.7

e6/l

9160.0

16945.3

1.43

455

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

144

1379

1.05

0.19

2.0

1.9

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

249

0.88

0.19

1.4

e6/l

112390.4

92939.0

0.07

178

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

783

1.06

0.19

1.1

u/ml

1.9

1.8

0.02

334

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

100

1.20

0.18

1.2

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

119

1.18

0.17

1.1

1.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.21

0.17

2.9

3.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.13

0.17

1.4

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

224

1.12

0.17

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

224

1.12

0.17

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

224

1.12

0.17

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.72

0.17

1.4

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

1.16

0.16

2.0

1.3

1.4

2.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

296

3033

0.97

0.16

3.6

4.0

30.0

30.6

0.53

234

2201

(3024263) Appearance of Synovial fluid

151

0.86

0.15

2.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.14

0.15

1.0

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

109

1136

0.96

0.15

1.3

miu/ml

174.4

213.6

0.76

538

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

420

0.93

0.15

1.3

1.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

0.81

0.14

1.6

1.3

23.3

52.6

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

227

1.10

0.14

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

227

1.10

0.14

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

227

1.10

0.14

1.1

—

(40768800) Prostate Pathology biopsy report

460

1.07

0.14

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

480

0.94

0.13

1.0

u/ml

0.2

0.7

0.73

120

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

122

1.15

0.13

5.6

3.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

122

1.15

0.13

1.1

1.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

344

1.08

0.13

1.2

1.4

pmol/l

286.4

310.1

0.20

264

(3050129) First trimester maternal screen panel - Serum or Plasma

113

1170

0.96

0.12

1.5

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

133

1.13

0.12

1.0

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

318

1.07

0.11

1.8

1.5

promille

1.6

1.4

0.20

246

(3008401) Mugwort IgE Ab [Units/volume] in Serum

681

1.04

0.11

1.0

1.1

u/ml

0.5

1.6

1.73

299

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

175

1791

0.98

0.10

1.6

1.5

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

251

1.08

0.10

3.5

2.1

ug/l

15.3

21.8

1.68

246

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

1.11

0.09

2.2

1.7

mg/l

1.7

1.6

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

1.06

0.09

1.6

1.2

mg/l

0.9

256.8

—

(4146454)

252

1.07

0.09

2.6

2.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

126

1.11

0.09

1.4

2.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.11

0.09

3.3

8.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.11

0.09

2.3

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

522

0.96

0.08

1.1

u/ml

3.8

4.8

0.36

213

(3012494) Peanut IgE Ab [Units/volume] in Serum

107

1.12

0.08

1.2

1.1

u/ml

1.0

8.8

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

226

0.93

0.08

1.1

u/ml

0.4

2.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.08

0.08

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

615

6101

1.01

0.07

2.5

ug/l

0.8

0.7

0.45

344

3321

(3039443) Prostate specific Ag panel - Serum or Plasma

930

0.98

0.05

1.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

564

1.03

0.05

1.1

u/ml

4.0

4.5

0.11

223

(4034850)

902

1.02

0.05

13.1

8.7

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

120

0.92

0.05

1.3

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

436

1.03

0.04

1.5

1.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

161

1.06

0.03

5.9

7.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

777

1.02

0.03

1.8

1.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

102

1.08

0.03

1.7

1.9

—

(3008898) HLA-B27 [Presence]

127

1257

1.01

0.02

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

113

1.06

0.01

1.0

1.1

—

(3003338) MCHC [Mass/volume]

2704

27026

1.00

0.01

22.8

15.4

g/l

333.7

334.1

1.67

2684

26843

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

267

0.97

0.01

1.4

1.6

mmol/l

7.4

7.7

0.19

165

(3027923) C peptide [Moles/volume] in Serum or Plasma

176

0.97

0.00

1.8

1.5

nmol/l

1.3

1.4

0.07

138

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

176

0.97

0.00

1.5

1.9

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

246

0.98

0.00

1.7

1.5

—

(3008295) Osmolality of Serum or Plasma

302

0.99

0.00

1.2

1.5

mosm/kgh2o

278.2

283.5

0.65

228

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

209

1.00

0.00

2.0

1.8

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

454

0.99

0.00

1.2

1.3

mmol/l

6.9

0.02

329

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

114

0.96

0.00

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

104

0.96

0.00

3.1

2.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

106

1.04

0.00

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

283

0.99

0.00

1.4

1.3

mmol/l

10.6

12.6

—

(4211845)

117

1.03

0.00

3.0

2.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.03

0.00

1.3

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

143

0.98

0.00

3.4

3.0

ug/l

1.3

1.4

0.07

130

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.98

0.00

1.0

1.2

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.1

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.00

0.00

1.4

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

0.0

1.7

—

167.7

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

5.3

—

0.3

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.0

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.95

0.00

1.0

1.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.95

0.00

1.0

1.1

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(3022689) Creatine [Moles/volume] in Urine

0.96

0.00

2.3

1.5

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.1

—

66.6

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.00

0.00

2.9

1.4

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.2

—

36.8

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

2.8

—

9.2

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.0

—

1.3

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.5

—

4209.6

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

0.95

0.00

1.0

1.1

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.0

1.8

—

793.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

2.5

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.94

0.00

1.1

2.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.98

0.00

1.6

1.4

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.95

0.00

1.0

1.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_BACT_BIR_OTHER_INF_AGENTS and mortality.

Females

Parameter	HR [95% CI]	p-value
AB1_BACT_BIR_OTHER_INF_AGENTS	1.888 [1.63, 2.18]	< 0.001
Birth year	0.997 [0.99, 1.0]	0.416

During the follow-up period (1.1.1998 — 31.12.2019), 912 out of 5197 females with AB1_BACT_BIR_OTHER_INF_AGENTS died.

Males

Parameter	HR [95% CI]	p-value
AB1_BACT_BIR_OTHER_INF_AGENTS	2.315 [1.97, 2.72]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.012

During the follow-up period (1.1.1998 — 31.12.2019), 852 out of 3876 males with AB1_BACT_BIR_OTHER_INF_AGENTS died.

Mortality risk

Mortality risk for people of age

years, who have AB1_BACT_BIR_OTHER_INF_AGENTS.

N-year risk	Females	Males
1	0.198%	0.503%
5	0.991%	2.864%
10	2.58%	7.067%
15	5.194%	12.643%
20	9.827%	21.262%

Relationships between endpoints

↥

Index endpoint: AB1_BACT_BIR_OTHER_INF_AGENTS – Bacterial, viral and other infectious agents

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Bacterial, viral and other infectious agents

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints